Higaki, Jitsuo
Komuro, Issei
Shiki, Kosuke
Lee, Ganghyuck
Taniguchi, Atsushi
Ikeda, Hiroshi
Kuroki, Daisuke
Nishimura, Seiichiro
Ogihara, Toshio
Article History
Received: 20 April 2016
Revised: 23 July 2016
Accepted: 18 August 2016
First Online: 20 October 2016
Competing interests
: JH received consulting and lecture fees and/or research funding from Astellas Pharmaceutical, Nippon Boehringer Ingelheim, Mochida Pharmaceutical, Daiichi Sankyo, Sumitomo Dainippon Pharmaceutical, MSD, Novartis Pharmaceutical, Teijin Pharmaceutical and Takeda Pharmaceutical. IK has received lecture fees, research funding and/or scholarship grants from Daiichi Sankyo, Sumitomo Dainippon Pharmaceutical, Takeda Pharmaceutical, Mitsubishi Tanabe Pharmaceutical, Nippon Boehringer Ingelheim, Ono Pharmaceutical, Astellas Pharmaceutical, Teijin Pharmaceutical, Sanofi, Kowa Company, Bayel Yakuhin and TOA EIYO. TO declares no conflict of interest. JH and IK were the Medical Experts and TO was the Coordinating Investigator of this study. KS, GL, AT, HI, DK and SN are employees of Nippon Boehringer Ingelheim.